CytoSorbents Corporation (CTSO)

[dr_lowenstein]

ACM, agree generally with your numbers, except that the A converts 10:1, From the Q

"During the nine months ended September 30, 2010, 12,862.78 Series B Preferred Shares were converted into 35,532,542 Common shares.During the nine months ended September 30, 2010, 819,563 Series A Preferred Shares were converted into 8,195,623 Common shares." Also remember that the convert share count is increasing constantly due to the dividend, Finally, there are about 39 million options granted, of which currently about 17 million are vested. That is how I got my approximate 250 number